Curosurf
Active substance: poractant alfa
SUSPENSION · PORACTANT ALFA 80 mg/mL
United StatesActive
Marketing holder: Chiesi USA, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- PORACTANT ALFA · 80 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12097-db21-70ab-9e7e-c98174ddfd68;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 10122-510
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ENDOTRACHEAL
Sources
- product · openFDA NDC · 10122-510 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10122-510 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10122-510 · Verified 2026-10-09 · open in source